A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

A Mayer; Roslyn Francis; S.K. Sharma; B. Tolner; C.J. Springer; J. Martin; G.M. Boxer; J. Bell; A.J. Green; J.A. Hartley; C. Cruickshank; J. Wren; K.A. Chester; R.H.J. Begent

doi:10.1158/1078-0432.CCR-06-0769

A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

A Mayer, Roslyn Francis, S.K. Sharma, B. Tolner, C.J. Springer, J. Martin, G.M. Boxer, J. Bell, A.J. Green, J.A. Hartley, C. Cruickshank, J. Wren, K.A. Chester, R.H.J. Begent

Research output: Contribution to journal › Article › peer-review

69 Citations (Scopus)

Original language	English
Pages (from-to)	6509-6516
Journal	Clinical Cancer Research
Volume	12
Issue number	21
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-0769
Publication status	Published - 2006

Access to Document

10.1158/1078-0432.CCR-06-0769

Cite this

Mayer, A., Francis, R., Sharma, S. K., Tolner, B., Springer, C. J., Martin, J., Boxer, G. M., Bell, J., Green, A. J., Hartley, J. A., Cruickshank, C., Wren, J., Chester, K. A., & Begent, R. H. J. (2006). A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. Clinical Cancer Research, 12(21), 6509-6516. https://doi.org/10.1158/1078-0432.CCR-06-0769

@article{5f8c514f854e4490adffbce82acbb4fe,

title = "A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug",

author = "A Mayer and Roslyn Francis and S.K. Sharma and B. Tolner and C.J. Springer and J. Martin and G.M. Boxer and J. Bell and A.J. Green and J.A. Hartley and C. Cruickshank and J. Wren and K.A. Chester and R.H.J. Begent",

year = "2006",

doi = "10.1158/1078-0432.CCR-06-0769",

language = "English",

volume = "12",

pages = "6509--6516",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "21",

}

Mayer, A, Francis, R, Sharma, SK, Tolner, B, Springer, CJ, Martin, J, Boxer, GM, Bell, J, Green, AJ, Hartley, JA, Cruickshank, C, Wren, J, Chester, KA & Begent, RHJ 2006, 'A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug', Clinical Cancer Research, vol. 12, no. 21, pp. 6509-6516. https://doi.org/10.1158/1078-0432.CCR-06-0769

A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. / Mayer, A; Francis, Roslyn; Sharma, S.K. et al.
In: Clinical Cancer Research, Vol. 12, No. 21, 2006, p. 6509-6516.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

AU - Mayer, A

AU - Francis, Roslyn

AU - Sharma, S.K.

AU - Tolner, B.

AU - Springer, C.J.

AU - Martin, J.

AU - Boxer, G.M.

AU - Bell, J.

AU - Green, A.J.

AU - Hartley, J.A.

AU - Cruickshank, C.

AU - Wren, J.

AU - Chester, K.A.

AU - Begent, R.H.J.

PY - 2006

Y1 - 2006

U2 - 10.1158/1078-0432.CCR-06-0769

DO - 10.1158/1078-0432.CCR-06-0769

M3 - Article

C2 - 17085666

SN - 1078-0432

VL - 12

SP - 6509

EP - 6516

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 21

ER -